Sensitivity analysis using the Fine–Gray subdistribution hazard model.

Bergqvist, Rita; Ahlqvist, Viktor H.; Lundberg, Michael; Hergens, Maria-Pia; Sundström, Johan; Bell, Max; Magnusson, Cecilia

doi:10.1371/journal.pmed.1003820.s003

pmed.1003820.s003.docx (22.69 kB)

Sensitivity analysis using the Fine–Gray subdistribution hazard model.

journal contribution

posted on 2021-10-14, 17:24 authored by Rita Bergqvist, Viktor H. Ahlqvist, Michael Lundberg, Maria-Pia Hergens, Johan Sundström, Max Bell, Cecilia Magnusson

(DOCX)

History

Usage metrics

Keywords

randomized clinical trials medical prevention according low disposable income finding needs confirmation emulated target trial current recommendations also coronavirus disease 2019 coa reductase inhibitors 29 february 2020 11 november 2020 female ), 169 876 ), followed available observational studies 545 individuals died statin treatment initiated 1 march 2020 1 march 2019 study design flaws recorded statin dispensation 0 years ),modest negative association confounder adjusted hr 19 risk groups cohort study included 0 versus 58 statin treatment initiators statin treatment observational design adjusted hr 01 ),study include statin users dispensation data 642 individuals versus 1 versus 46 versus 45 versus 25 xlink ">swedish cause substantial heterogeneity pleiotropic effects often diagnosed n level education including 765 immune mechanisms hazard ratios discussed due crowded housing continued use antihypertensive treatments 7 %),4 %),

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Sensitivity analysis using the Fine–Gray subdistribution hazard model.

History

Usage metrics

Categories

Keywords

Licence

Exports